Regeneron faces new biosimilar threats; An AI biotech lays off staff
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what could make this type of story better? Drop us a line! Today, a brief rundown of news from Boehringer Ingelheim, as well as notes on GSK, …